Aims & Scope
The Journal of Applied Nanoscience (JOAN) is a peer-reviewed, open-access journal published by Directive Publications and dedicated to applied nanoscience at the interface of nanomaterials, nanomedicine and nanotechnology. The journal reports rigorous, original work that translates nanoscale phenomena into practical advances for health, engineering and the life sciences, with particular strength in nanoparticle-based drug delivery, nano-oncology and radiotherapy enhancement, nanodiagnostics and biosensing.
We welcome original research, reviews, methodological papers, case reports and editorials spanning nanoparticle synthesis and characterization, functional and theranostic nanomaterials, high-Z nanoparticles for tumor treatment, Monte Carlo dose modeling, circulating-biomarker detection, and nanotoxicology and biocompatibility. Submissions addressing both fundamental mechanisms and applied, translational outcomes are encouraged.
Intended for materials scientists, biomedical engineers, pharmaceutical researchers, oncology and imaging specialists, and nanotechnology practitioners, JOAN connects investigators worldwide through a trusted, internationally accessible platform.
Every submission undergoes double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) license with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. The journal follows COPE ethical principles.
Subject Coverage
Journal of Applied Nanoscience welcomes original research, reviews, and case reports across the following core areas:
Research Topics
Core subject areas published in Journal of Applied Nanoscience — explore related research across our journals.
Articles
Use and effects of the particles, heavy electrons, and x-ray radiation for hadrontherapy leading to or after harmful tissue transplantation
Improving cancer research multiforme with high-z dna nanoparticles for tumour collider treatment optimisation using high-Z DNA Particles Radiation Drugs
Analytical evaluation of rna molecules that impact crucial human reaction gene as putative biomarkers for illness with neural malaria
Frequently Asked Questions
What topics does the Journal of Applied Nanoscience cover?
JOAN covers applied nanoscience across nanomaterials and nanomedicine: nanoparticle drug delivery, nano-oncology and radiotherapy/hadrontherapy enhancement with high-Z nanoparticles, nanoparticle synthesis and characterization, theranostic and functional nanomaterials, nanodiagnostics and biosensing, and nanotoxicology. We prioritize work that translates nanoscale science into practical applications.
Who should publish in or read the Journal of Applied Nanoscience?
The journal serves materials scientists, biomedical and pharmaceutical engineers, nanomedicine and oncology researchers, imaging and dosimetry specialists, and nanotechnology practitioners. Authors working on applied nanomaterials, nanoparticle therapeutics or nano-enabled diagnostics, and readers seeking current open-access nanoscience research, are an ideal fit.
Is the Journal of Applied Nanoscience open access, and what license is used?
Yes. Every accepted article is published open access under a Creative Commons Attribution (CC-BY 4.0) license, so anyone can read, share and reuse the work with attribution. Authors retain copyright, and each article receives a permanent Crossref DOI for citation and long-term availability.
How does peer review work at the Journal of Applied Nanoscience?
All submissions undergo double-blind peer review, where author and reviewer identities are mutually concealed to support impartial evaluation. Manuscripts are assessed on scientific rigor, methodological soundness, novelty and relevance to applied nanoscience. The journal follows COPE ethical principles for handling submissions, conflicts of interest and corrections.
What article types can I submit to the Journal of Applied Nanoscience?
JOAN accepts original research articles, review and mini-review articles, methodological and characterization papers, short communications, case reports and editorials. Reviews and systematic syntheses on nanoparticle drug delivery, nanomaterial characterization or nanotechnology in cancer therapy are especially welcome for their citation value.
Is there an article-processing charge, and are waivers available?
As an open-access journal, JOAN applies an article-processing charge (APC) only on acceptance, which funds peer review, production, DOI registration and permanent hosting. Waivers and discounts are available; authors should contact the editorial office regarding the current fee and waiver eligibility before or during submission.
Is the Journal of Applied Nanoscience indexed and discoverable?
Every JOAN article is assigned a Crossref DOI and is discoverable through OpenAlex and Google Scholar, and the journal exposes an OAI-PMH endpoint for metadata harvesting. As a new title, JOAN is also working toward eligibility for additional scholarly databases such as DOAJ; current indexing status is listed on the journal page.
Does the Journal of Applied Nanoscience have an ISSN?
Yes. The Journal of Applied Nanoscience holds the online ISSN 2996-1726, which uniquely identifies the journal across catalogs, indexers and citation systems and supports consistent referencing of its open-access content.